Lab21 and ITOR launch Clinical Genomics Center in USA

Lab21 Limited has announced the launch of a new Clinical Genomics Center at the Greenville Hospital System (GHS) Memorial Medical Campus in Greenville, South Carolina. The center will be located in the GHS Institute for Translational Oncology Research (ITOR) as part of an on-going collaboration to facilitate the introduction of complex biomarker analysis into routine cancer patient management.

The announcement represents a long-standing commitment from the local oncology community and lab21 to introduce state-of-the-art next-generation sequencing (NGS) technology as part of its growing translational medicine clinical portfolio in the US. The center itself was facilitated through a strategic relationship with Life Technologies who are providing their new Ion Torrent Personal Genome Machine as the key launch platform technology.

“Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey,” said Dr. Joe Stephenson, medical director for ITOR. “This genomics center is another major step towards fulfilling our vision to provide personalized cancer care – better enabling us to offer the right drug, at the right time, to the right patient.”

Lab21’s CEO, Graham Mullis, said: “This is a major step forward for Lab21 in North America and we are delighted to be working with Dr. Joe Stephenson and the team at ITOR in this fast changing market of personalized medicine. The establishment of this center underlines our commitment to our personalized medicine strategy and to introduce state-of-the-art molecular services and products into North America. It also reinforces our relationship with ITOR and the potential to use this technology for clinical trial applications with a view to identifying new biomarkers which can subsequently build our proprietary companion diagnostic portfolio. Importantly, it marks our intention to utilize this NGS technology in other therapeutic areas in addition to oncology. Lab21 is a company with an established business in infectious diseases, particularly virology, and we are already negotiating new contracts to exploit this expertise using NGS technology.”